OXACILLIN

Generic: OXACILLIN SODIUM

Eugia US LLCManufacturer
INTRAVENOUSRoute
OXACILLIN SODIUMActive Substance
2013-01-18Original Approval

OXACILLIN is FDA application ANDA201538, sponsored by EUGIA PHARMA SPECLTS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DRUG INEFFECTIVE
97 reports
2
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS
68 reports
3
ACUTE KIDNEY INJURY
66 reports
4
PYREXIA
59 reports
5
RASH
55 reports
6
OFF LABEL USE
46 reports
7
TOXIC EPIDERMAL NECROLYSIS
45 reports
8
DRUG INTERACTION
42 reports
9
PNEUMONIA
41 reports
10
RENAL FAILURE
40 reports